HealthStream (NASDAQ:HSTM) was downgraded by stock analysts at ValuEngine from a “hold” rating to a “sell” rating in a report issued on Monday, February 5th.
A number of other research firms have also weighed in on HSTM. Robert W. Baird reduced their price objective on HealthStream from $30.00 to $28.00 and set an “outperform” rating for the company in a research note on Wednesday, October 25th. Zacks Investment Research upgraded HealthStream from a “hold” rating to a “strong-buy” rating and set a $27.00 target price on the stock in a research report on Wednesday, October 25th. Canaccord Genuity reiterated a “hold” rating and issued a $25.00 price objective on shares of HealthStream in a report on Monday, October 23rd. BidaskClub cut HealthStream from a “hold” rating to a “sell” rating in a report on Wednesday, January 31st. Finally, Needham & Company LLC cut HealthStream from a “buy” rating to a “hold” rating in a report on Wednesday, October 25th. One equities research analyst has rated the stock with a sell rating, six have issued a hold rating and two have given a buy rating to the stock. The company presently has an average rating of “Hold” and an average target price of $24.83.
HealthStream (NASDAQ HSTM) traded down $0.23 during trading on Monday, hitting $22.23. The stock had a trading volume of 107,251 shares, compared to its average volume of 94,778. The firm has a market cap of $708.74, a PE ratio of 123.50, a price-to-earnings-growth ratio of 4.74 and a beta of 0.90. HealthStream has a 52-week low of $21.15 and a 52-week high of $31.53.
A number of hedge funds and other institutional investors have recently made changes to their positions in HSTM. Stevens Capital Management LP purchased a new stake in shares of HealthStream during the third quarter worth $367,000. BNP Paribas Arbitrage SA increased its position in shares of HealthStream by 65.6% during the third quarter. BNP Paribas Arbitrage SA now owns 13,466 shares of the technology company’s stock worth $315,000 after acquiring an additional 5,335 shares during the period. Cornerstone Capital Management Holdings LLC. purchased a new stake in shares of HealthStream during the third quarter worth $448,000. Wells Fargo & Company MN grew its stake in shares of HealthStream by 48.6% during the third quarter. Wells Fargo & Company MN now owns 32,362 shares of the technology company’s stock worth $756,000 after purchasing an additional 10,581 shares in the last quarter. Finally, Algert Global LLC acquired a new position in shares of HealthStream during the third quarter worth $1,948,000. 73.99% of the stock is currently owned by institutional investors.
ILLEGAL ACTIVITY NOTICE: This piece was first posted by Dispatch Tribunal and is the property of of Dispatch Tribunal. If you are accessing this piece on another website, it was illegally stolen and republished in violation of international trademark & copyright laws. The legal version of this piece can be viewed at https://www.dispatchtribunal.com/2018/02/13/healthstream-hstm-downgraded-by-valuengine-to-sell.html.
HealthStream, Inc (HealthStream) provides workforce, patient experience and provider solutions for healthcare organizations. The Company operates in three segments: HealthStream Workforce Solutions, HealthStream Patient Experience Solutions and HealthStream Provider Solutions. HealthStream’s products and services are organized into three segments: Workforce Solutions, Patient Experience Solutions, and Provider Solutions.
To view ValuEngine’s full report, visit ValuEngine’s official website.
Receive News & Ratings for HealthStream Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for HealthStream and related companies with MarketBeat.com's FREE daily email newsletter.